Abstract 3778: Preclinical evaluation of BG-C137, a potential first-in-class FGFR2b-targeting ADC, for the treatment of FGFR2b-expressing cancer
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Yibin Xu, Xiaolin Su, Qiming Xu, Mengran Qian, Taichang Zhang, Mei-Hsuan Tsai, Ruyue Ji, Junna Jiang, Bin Shao, Yuan Zhuang, Jiyuan Zhang, Xiaomin Song, Zhitao Wan, Xiaoyan Tang, Yue Wu, Charng-Sheng Tsai, Chichi Huang, Lai Wang, Zhirong Shen
Institution: BeiGene (China)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409689084